MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS)

    S. Luo, G. Stebbins, Y. Liu, C. Goetz (Houston, TX, USA)

    Objective: Test if differential item functioning (DIF) due to gender, age, race/ethnicity or education level is present in UDysRS items.    Background: Testing a rating…
  • 2017 International Congress

    Tics Exacerbations in Adults with Tic Disorders: A Case series

    S. Schaefer, C. Chow, E. Louis, D. Robakis (New Haven, CT, USA)

    Objective: To identify patterns of tic re-emergence in adult patients with a history of childhood tics. Background: Tics and Tourette syndrome (TS) have been described…
  • 2017 International Congress

    Efficacy and Safety of a 2 mL Dilution of AbobotulinumtoxinA Compared With Placebo in Adult Patients With Cervical Dystonia

    M. Lew, D. Snyder (Los Angeles, CA, USA)

    Objective: To determine the efficacy and safety of a 500 U/2 mL dilution of aboBoNT-A as compared to placebo in patients with cervical dystonia (CD).…
  • 2017 International Congress

    Gpi DBS for Dystonia in Pediatric Patients

    S. Aydın, H. Canaz (Istanbul, Turkey)

    Objective: Dystonia is a movement disorder in which involuntary sustained or intermittent muscle contractions cause twisting and repetitive movements, abnormal postures, or both. It can…
  • 2017 International Congress

    Towards a reappraisal of Status Dystonicus : a cohort study

    X. VASQUES, E. Nerrant, V. GONZALEZ, C. MILESI, N. MENJOT, G. CAMBONIE, J. PEREZ, A. Bonafe, P. Coubes, L. CIF (Montpellier, France)

    Objective: The objective of the study is to find the key factors driving dystonia patients at risk to develop SD.  Background: Status Dystonicus (SD) is…
  • 2017 International Congress

    Head turning onset and velocity in response to a peripheral visual stimulus in cervical dystonia patients, their unaffected relatives with and without abnormal temporal discrimination and healthy controls.

    I. Beiser, B. Quinlivan, E. McGovern, L. Williams, S. Narasimham, O. Killian, R. Beck, S. O'Riordan, J. Butler, R. Reilly, M. Hutchinson (Dublin 4, Ireland)

    Objective: We postulate that cephalomotor responses (onset of head turning and speed of head turning) to the appearance of a novel peripheral visual stimulus will…
  • 2017 International Congress

    Cognitive Function is Preserved 10 Years Following DBS in People with Dystonia

    E. Hogg, J. Eskenazi, E. During, J. Wertheimer, R. Alterman, M. Tagliati (Los Angeles, CA, USA)

    Objective: To study cognitive function in people with dystonia chronically treated with Deep Brain Stimulation (DBS). Background: The impact of DBS on cognition is a matter of…
  • 2017 International Congress

    Oculogyric Crisis Due to Treatment With flunarizine

    M. Kurtz, D. Ballesteros, J. Crespo, J. Perez Garcia, J. Lopez, I. Lagger, F. Knorre (CF, Argentina)

    Objective: To report the first case of oculogyric crisis (OC) secondary to flunarizine. Background: Oculogyric crisis (OC) are an infrequent neurologic complication of dopamine antagonists…
  • 2017 International Congress

    Baseline predictors for clinical progression after 48 month follow-up in early Parkinson’s disease from the DeNoPa cohort

    B. Mollenhauer, J. Zimmermann, F. Sixel-Döring, N. Focke, T. Wicke, J. Ebentheuer, M. Schaumburg, E. Lang, C. Trenkwalder (Kassel, Germany)

    Objective: To analyze clinical progression at enrolment in drug-naïve Parkinson’s disease (PD) subjects over 48 months of follow-up, we describe the annual rate of progression…
  • 2017 International Congress

    The Pull Test in healthy subjects and Parkinson´s disease: quantitative pull-force measure, postugraphic and electromyographic analysis

    J.R. Perez-Sanchez, B. DeLaCasa-Fages, A. Contreras, J.M. Velázquez, A. Muñoz-González, F. Grandas (Madrid, Spain)

    Objective: To study and compare in healthy subjects and patients with Parkinson´s disease (PD) the destabilizing force needed to reach the limit of stability (LoS), the displacements of…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley